Concord Wealth Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Concord Wealth Partners’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-103	Closed	-$17K	–	1079
2021 Q2	$17K	Buy	103 +85	+472%	+$14.2K	﹤0.01%	543
2021 Q1	$3K	Buy	+18	New	+$2.44K	﹤0.01%	795

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Concord Wealth Partners's PRAH Position: Q3 2021 in Review

Concord Wealth Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 103 shares — an estimated $17K sold.

Concord Wealth Partners first reported a position in PRAH in Q1 2021 and held it in 2 quarters. The position peaked at $17K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Concord Wealth Partners reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Concord Wealth Partners sold 103 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $17K.
Concord Wealth Partners first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 2 quarters.
Concord Wealth Partners's PRA Health Sciences, Inc. position peaked at $17K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Concord Wealth Partners's 13F filing for Q3 2021, filed 9 Nov 2021.